Pershing Square Capital Management

Scot Sellers to Be Named Chairman of the Board of Howard Hughes Holdings Inc. at Company’s Upcoming Annual Meeting

Retrieved on: 
Thursday, April 4, 2024
Irvine Company, Growth, Blackstone Inc., Howard Hughes, Cornell University, Mergers and acquisitions, MPC, Acquisition, GGP Inc., City, HHH, The, Partner, Collection, Pershing Square Capital Management, Mergers & Acquisitions, Ackman

THE WOODLANDS, Texas, April 04, 2024 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) announced today that long-time Howard Hughes board member Scot Sellers will be named Chairman of its Board of Directors at HHH’s upcoming annual meeting. Sellers will succeed Pershing Square Capital Management, L.P. (“Pershing Square”) Founder and CEO Bill Ackman, who will be retiring from the HHH board after serving as its chairman since founding Howard Hughes in 2010. Pershing Square Partner Ben Hakim is being nominated for the Howard Hughes board to replace Ackman. Pershing Square intends to remain a major, long-term shareholder of HHH.

Key Points: 
  • Long-time HHH Board Member and former Archstone CEO to succeed Bill Ackman as Board Chairman;
    THE WOODLANDS, Texas, April 04, 2024 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) announced today that long-time Howard Hughes board member Scot Sellers will be named Chairman of its Board of Directors at HHH’s upcoming annual meeting.
  • Pershing Square Partner Ben Hakim is being nominated for the Howard Hughes board to replace Ackman.
  • Sellers has served on the Board of Directors of Howard Hughes since the company’s inception.
  • Sellers currently serves on the board of The Irvine Company and is Chairman of the Board of Maui Land & Pineapple Company.

Sarissa Capital Believes Amarin Stock Is Meaningfully Undervalued and Has Increased Its Ownership

Retrieved on: 
Monday, December 4, 2023
Banking, Professional Services, Finance, Patient, Pershing Square Capital Management, Sarissa, Partnership, Professional corporation, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa believes Amarin’s stock is significantly undervalued.
  • We hope that recent progress detailed below will cause the stock to begin to reflect the value we think it has.
  • We have never sold any shares of Amarin and have only increased our position since we made the investment.
  • We are pleased with the progress that Amarin has made to date and expect the value to be reflected in the stock price over time.

18th Double Helix Medals dinner raises more than $10 million

Retrieved on: 
Monday, November 27, 2023
Cold Spring Harbor Laboratory, Invention, Renal cell carcinoma, Perception, DRS, Research, Howard Hughes Corporation, Double Helix Medal, CSHL, Medicine, Pershing Square Capital Management, Nobel Prize, Summa Corporation, MD Anderson Cancer Center, FDA, Immunotherapy, CBS, Lung cancer, Cancer, Natural history, Ipilimumab, Rivka Oxman, Entomology, American Museum, Museum, SPRING, Environment, Biology, Education, Pharmaceutical industry, Physiology

COLD SPRING HARBOR, N.Y., Nov. 27, 2023 /PRNewswire/ -- On November 15, Cold Spring Harbor Laboratory (CSHL) held its 18th annual Double Helix Medals dinner (DHMD) at the American Museum of Natural History in New York City.

Key Points: 
  • COLD SPRING HARBOR, N.Y., Nov. 27, 2023 /PRNewswire/ -- On November 15, Cold Spring Harbor Laboratory (CSHL) held its 18th annual Double Helix Medals dinner (DHMD) at the American Museum of Natural History in New York City.
  • CBS journalist Lesley Stahl returned to emcee the awards dinner, which honored Neri Oxman & William Ackman and 2018 Nobel laureate Jim Allison.
  • After receiving the Double Helix Medal, Oxman and Ackman announced an extraordinary gift, further breaking the event's fundraising record to support scientific research and education at CSHL.
  • Since the inaugural gala in 2006 honoring Muhammed Ali, the DHMD has raised over $60 million to support CSHL's biological research and education programs.

Middle East Forum Launches 'Divest from Qatar' Campaign

Retrieved on: 
Friday, October 27, 2023
MEF, Terrorism, Middle East Forum, KKR, Qatar Investment Authority, Congress, Pershing Square Capital Management, Ted Leonsis, Affinity Partners, QIA, Terror, Apollo Global Management, Investment, Blackstone, Online shopping, Cryptocurrency, Hamas

PHILADELPHIA, Oct. 27, 2023 /PRNewswire/ -- The Middle East Forum (MEF) is spearheading a grassroots campaign urging American investment firms and privately-held corporations to divest from Qatar in response to its support for the Hamas-led massacre in Israel.

Key Points: 
  • PHILADELPHIA, Oct. 27, 2023 /PRNewswire/ -- The Middle East Forum (MEF) is spearheading a grassroots campaign urging American investment firms and privately-held corporations to divest from Qatar in response to its support for the Hamas-led massacre in Israel.
  • We invite all Americans to participate in this easy, quick, digital letter-writing campaign.
  • MEF calls on the public to participate in a #DivestFromQatar campaign targeting top U.S. investors.
  • The Middle East Forum, a non-profit organization, promotes American interests in the Middle East and protects Western civilization from Islamism.

Pershing Square SPARC Holdings, Ltd. Announces Launch and SPAR Distribution

Retrieved on: 
Friday, September 29, 2023
Professional Services, Finance, Transfer, DTC, IPO, SPARC, Sponsor, SPAR, Business analyst, Person, Prospectus, Acquisition, Pershing Square Capital Management, PSTH, Financial services, Security (finance), SPARS

Pershing Square SPARC Holdings, Ltd. (“SPARC”) today announced that the SEC has declared SPARC’s registration statement effective.

Key Points: 
  • Pershing Square SPARC Holdings, Ltd. (“SPARC”) today announced that the SEC has declared SPARC’s registration statement effective.
  • SPARC will shortly be distributing special purpose acquisition rights (“SPARs”) at no cost to former securityholders of Pershing Square Tontine Holdings, Ltd. (“PSTH”).
  • Pershing Square SPARC Sponsor, LLC, (“Sponsor”), an affiliate of Pershing Square Capital Management, L.P., serves as the sponsor of SPARC.
  • In connection with the distribution of SPARs, SPARC entered into a SPAR Rights Agreement with Continental Stock Transfer & Trust Company (“Continental”), as custodian and rights agent.

TCS Capital Delivers Open Letter to the Yelp Board of Directors

Retrieved on: 
Tuesday, May 23, 2023
Well, Exercise, Face, Pershing Square Capital Management, Culture, Table tennis rubber, Wall Street, Research, History, Angi Inc., Sale, TCS, Depression, EBITDA, Machine learning, Hearing, CFO, Growth, AI, CPO, Ligamentous laxity, Security (finance), Management, Cryptocurrency, Retail, Yelp

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- TCS Capital Management, LLC (together with its affiliates, “TCS”), one of the largest shareholders of Yelp, Inc. (“Yelp” or the “Company”) (NYSE: YELP) with beneficial ownership of more than 4% of the outstanding common stock of the Company, today announced that it has delivered a letter to the Company’s Board of Directors.

Key Points: 
  • TCS Capital Management, LLC and myself (“TCS,” “we” or “us”) beneficially own more than 4% of the outstanding shares of common stock of Yelp Inc. (“Yelp” or the “Company”), making us one of the Company’s five largest stockholders.
  • Amid this horrific underperformance, Yelp has become one of the most undervalued stocks that we have encountered in our 22 years as an investment firm.
  • Furthermore, Yelp stands to benefit greatly from increased integration of AI and machine learning, especially with regard to improving the quality and value of Yelp reviews and recommendations.
  • In conclusion, we demand that the Board act to advance stockholder interests by immediately commencing a rigorous exploration of strategic alternatives.

Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide

Retrieved on: 
Tuesday, February 28, 2023
Professional Services, Health, Finance, Banking, Pharmaceutical, Biotechnology, ALL, Annual general meeting, WORK, Amarin, Mass meeting, Patient, Professional corporation, Wall Street, Pershing Square Capital Management, Holding company, Security (finance), Sarissa

Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Amarin shareholders have sent a loud and clear message repudiating the incumbent Amarin board.
  • Sarissa thanks fellow shareholders for their support in a resounding victory against the Amarin board.
  • Sarissa Capital Management LP (“Sarissa Capital”), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in connection with the solicitation of shareholders of Amarin Corporation plc (the “Company”) at the general meeting of the Company for the election of Sarissa Capital’s slate of highly-qualified nominees (the “General Meeting”).
  • The definitive proxy statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital’s proxy solicitor, D.F.

Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review

Retrieved on: 
Monday, February 27, 2023
Asset Management, Professional Services, Finance, Biotechnology, Trust, GSK, Collection, Appendix, Directorate of Research and Civil Affairs, Letter, Growth, Tax, Pershing Square Capital Management, Sale, Fluticasone furoate/umeclidinium bromide/vilanterol, Security (finance), Pharmaceutical industry, Management, Holding company, Risk management, Recycling, Revefenacin, Research

We invested in Theravance because we believe the Company is worth substantially more than its current market value.

Key Points: 
  • We invested in Theravance because we believe the Company is worth substantially more than its current market value.
  • Investors have substantial concerns with Theravance’s capital allocation, approach to executive compensation and operating costs, and management’s choice of ultimate strategic direction.
  • We have also proposed entering into a formal cooperation agreement in order to assist in unlocking Theravance’s value and improving governance and oversight.
  • Such rights include the right to call special meetings…”14
    To date, the Company has not committed to any of these steps.

Sarissa Capital Urges Amarin Shareholders to Vote “FOR” Necessary Change

Retrieved on: 
Monday, February 20, 2023
Biotechnology, Finance, Health, Professional Services, Cardiology, MAKE, Patient, Sale, BUT, Sequah Medicine Company, History, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Pershing Square Capital Management, Bank, Management, Internet service provider, Auction, Security (finance), Sarissa, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa urges Amarin shareholders to vote “FOR” necessary change at our upcoming shareholder meeting.
  • Amarin is at a critical juncture where strategic decisions must be made by a board that seeks to leverage the strengths of the company’s assets for the benefit of shareholders.
  • Visit our website at www.freeamarin.com for helpful information about Sarissa and the need for change at Amarin.
  • The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, SUBMIT YOUR VOTE ON OR BEFORE TUESDAY, FEBRUARY 21, 2023.

Sarissa Capital Uncovers That Amarin’s Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do So

Retrieved on: 
Wednesday, February 15, 2023
Professional Services, Health, Finance, Pharmaceutical, Cardiology, Biotechnology, MAKE, Sarissa, BUT, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Pershing Square Capital Management, Auction, Security (finance), Internet service provider, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa Capital, in voting its shares, uncovered that Amarin’s registrar, the firm retained by Amarin to receive and process proxy cards, had not been instructed to accept blue proxy cards even though legally required to do so.
  • Amarin’s registrar believed it was only authorized to accept and process the white proxy cards.
  • Fortunately for shareholders, Sarissa acted to correct this problem and all votes that have been or will be submitted on the blue proxy card will be accepted.
  • IF YOU ALREADY VOTED “FOR” ALL PROPOSALS AND SUBMITTED YOUR BLUE PROXY CARD, THERE IS NOTHING ELSE YOU NEED TO DO TO SUPPORT SARISSA’S NOMINEES.